SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 17 of 100
Health
There’s been a strange fluctuation in the health care job market during the pandemic
By
Sy Mukherjee
Health
Rumors swirl about an AstraZeneca and Gilead megadeal—but it doesn’t make sense
By
Sy Mukherjee
Newsletters
The health care system is stacked against black lives
By
Sy Mukherjee
Health
5 companies to keep an eye on following the world’s largest cancer conference
By
Sy Mukherjee
Newsletters
Getting back to the office in the midst of coronavirus is going to be complicated
By
Sy Mukherjee
Health
The CDC says antibody tests shouldn’t be used to make return-to-work decisions
By
Sy Mukherjee
Newsletters
Moderna’s coronavirus vaccine expectations game
By
Sy Mukherjee
Health
The health care industry’s winners and losers in the midst of the pandemic
By
Sy Mukherjee
Health
Tobacco giants are getting into the coronavirus vaccine race
By
Sy Mukherjee
Health
Moderna releases promising—but early—new coronavirus vaccine data
By
Sy Mukherjee
Newsletters
Antibody testing’s chicken and egg problem
By
Sy Mukherjee
Politics
4 takeaways from the House Democrats’ new $3 trillion stimulus bill
By
Nicole Goodkind
and
Sy Mukherjee
Health
Antibody testing will be key—once we understand what the results mean
By
Sy Mukherjee
Newsletters
Gilead’s moral (and financial) COVID-19 conundrum
By
Sy Mukherjee
Health
Remdesivir is the first coronavirus treatment. So why is Gilead’s stock plunging?
By
Sy Mukherjee